Skip to main content

Table 2 Presence of circuit coagulation in the overall cohort

From: Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study

 

Absent

Present

P

Circuit coagulation

255/309

54/309

 

17.5% (13.2 – 21.7%)1

  Performed treatment time (mean min ± sd)

219 ± 47

170 ± 49

< 0.0001

  Treated blood volume (mean litres ± sd)

54.9 ± 13.6

40.5 ± 13.2

< 0.0001

Circuit coagulation with premature termination2

262/309

47/309

 

15.2% (11.4 – 19.7%)1

Complete circuit coagulation3

296/309

13/309

 

4.2% (2.2% – 7.1%)1

  1. 1proportion with 95% CI.
  2. 2shortening of scheduled dialysis session length because of circuit clotting.
  3. 3massive clotting with inability to retransfuse blood from extracorporeal circuit.
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us